Mirum Pharmaceuticals, Inc. — Investor Relations & Filings
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases, with a primary focus on debilitating liver conditions affecting both children and adults. The company's lead commercial product is LIVMARLI® (maralixibat), an oral solution for the treatment of cholestatic pruritus in patients with Alagille syndrome. Mirum's clinical pipeline is advancing other potential treatments, including volixibat, for various rare cholestatic liver diseases. The company's mission is to transform the treatment landscape for patients with significant unmet medical needs by advancing its scientific programs from discovery through commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-05-06 | English | |
| 8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-05-04 | English | |
| 8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-04-27 | English | |
| ARS - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-04-24 | English | |
| 8-K/A - Mirum Pharmaceuticals, Inc. (0001759425) (Filer) | 2026-04-08 | English |
Browse filings by year
9 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BY-HEALTH CO.,LTD
Researches, develops, and distributes dietary supplements, …
|
300146 | CN | Manufacturing |
|
C4 Therapeutics, Inc.
Clinical-stage biopharma developing targeted protein degrad…
|
CCCC | US | Manufacturing |
|
Cadrenal Therapeutics, Inc.
A late-stage biopharmaceutical company developing novel ant…
|
CVKD | US | Manufacturing |
|
CalciMedica, Inc.
Develops CRAC channel inhibitors for acute inflammatory and…
|
CALC | US | Manufacturing |
|
Calidi Biotherapeutics, Inc.
Develops stem cell platforms to deliver oncolytic viruses f…
|
CLDI | US | Manufacturing |
|
Calliditas Therapeutics
Biopharma company developing and commercializing treatments…
|
CALTX | SE | Manufacturing |
|
Callitas Health Inc.
Clinical-stage biomedical company developing pharma and OTC…
|
MPHMF | CA | Manufacturing |
|
CALTH. Inc
Develops in vitro diagnostic tools for point-of-care and se…
|
402420 | KR | Manufacturing |
|
Cambrex
A CDMO providing drug substance, drug product, and analytic…
|
CBM | US | Manufacturing |
|
CAMBRIDGE NUTRITIONAL SCIENCES PLC
Develops and manufactures diagnostic tests for food sensiti…
|
CNSL | GB | Manufacturing |
Mirum Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31228/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31228 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31228 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31228 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31228}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Mirum Pharmaceuticals, Inc. (id: 31228)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.